APA引用形式

Corey, G. R., Kollef, M. H., Shorr, A. F., Rubinstein, E., Stryjewski, M. E., Hopkins, A., & Barriere, S. L. (2014). Telavancin for Hospital-Acquired Pneumonia: Clinical Response and 28-Day Survival. American Society for Microbiology.

シカゴスタイル引用形

Corey, G. Ralph, Marin H. Kollef, Andrew F. Shorr, Ethan Rubinstein, Martin E. Stryjewski, Alan Hopkins, , Steven L. Barriere. Telavancin for Hospital-Acquired Pneumonia: Clinical Response and 28-Day Survival. American Society for Microbiology, 2014.

MLA引用形式

Corey, G. Ralph, et al. Telavancin for Hospital-Acquired Pneumonia: Clinical Response and 28-Day Survival. American Society for Microbiology, 2014.